Haemonetics jumped because of increased plasma product usage
Haemonetics jumped because of increased plasma product usage
surger more than 17% after news that CSL Plasma had expanded the use of the company’s products. I know that this may not sound like much but think about it this way. In the broader marker, mostly the entire market shifts because of AI or oil. Pharma stocks are untouched and depend on the progress in healthcare. Should be a good idea to invest in some pharma stocks. What do you think?
Healthcare stocks can offer some diversification from AI and oil-driven market moves, but they’re not immune to broader volatility. Company fundamentals, clinical progress, and valuations still matter a lot.
You make a great point about needing exposure outside of the usual AI giants. I have been watching healthcare lately and think there is a lot of potential if you look at the right firms.